Tremblay T, Bergeron C, Gagnon D, Berube C, Voyer N, Richard D
ACS Med Chem Lett. 2023; 14(2):217-222.
PMID: 36793432
PMC: 9923836.
DOI: 10.1021/acsmedchemlett.2c00531.
Kumura K, Wakiyama Y, Ueda K, Umemura E, Hirai Y, Yamada K
J Antibiot (Tokyo). 2017; 70(12):1112-1121.
PMID: 29115289
DOI: 10.1038/ja.2017.143.
Wakiyama Y, Kumura K, Umemura E, Masaki S, Ueda K, Sato Y
J Antibiot (Tokyo). 2017; 71(2):298-317.
PMID: 29089594
DOI: 10.1038/ja.2017.114.
Kumura K, Wakiyama Y, Ueda K, Umemura E, Watanabe T, Yamamoto M
J Antibiot (Tokyo). 2017; .
PMID: 28676716
DOI: 10.1038/ja.2017.59.
Wakiyama Y, Kumura K, Umemura E, Ueda K, Watanabe T, Yamada K
J Antibiot (Tokyo). 2017; 70(8):888-906.
PMID: 28559581
DOI: 10.1038/ja.2017.54.
Synthesis and structure-activity relationships of novel lincomycin derivatives part 3: discovery of the 4-(pyrimidin-5-yl)phenyl group in synthesis of 7(S)-thiolincomycin analogs.
Wakiyama Y, Kumura K, Umemura E, Masaki S, Ueda K, Sato Y
J Antibiot (Tokyo). 2016; 70(1):52-64.
PMID: 27703159
DOI: 10.1038/ja.2016.114.
Synthesis and antibacterial activity of novel lincomycin derivatives. I. Enhancement of antibacterial activities by introduction of substituted azetidines.
Kumura K, Wakiyama Y, Ueda K, Umemura E, Watanabe T, Shitara E
J Antibiot (Tokyo). 2016; 69(6):440-5.
PMID: 26758495
DOI: 10.1038/ja.2015.134.
Synthesis and structure-activity relationships of novel lincomycin derivatives. Part 1. Newly generated antibacterial activities against Gram-positive bacteria with erm gene by C-7 modification.
Wakiyama Y, Kumura K, Umemura E, Ueda K, Masaki S, Kumura M
J Antibiot (Tokyo). 2015; 69(5):368-80.
PMID: 26669755
DOI: 10.1038/ja.2015.119.
Synthesis and structure-activity relationships of novel lincomycin derivatives. Part 2. Synthesis of 7(S)-7-deoxy-7-(4-morpholinocarbonylphenylthio)lincomycin and its 3-dimensional analysis with rRNA.
Wakiyama Y, Kumura K, Umemura E, Masaki S, Ueda K, Watanabe T
J Antibiot (Tokyo). 2015; 69(6):428-39.
PMID: 26669751
DOI: 10.1038/ja.2015.125.
